LWCFA
ALKS icon

Loring Wolcott & Coolidge Fiduciary Advisors’s Alkermes ALKS Stock Holding History

Loring Wolcott & Coolidge Fiduciary Advisors’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,250
Closed -$18K – 587
2020
Q1 		$18K Hold
1,250
– – ﹤0.01% 474
2019
Q4 		$26K Buy
+1,250
New +$24.8K ﹤0.01% 504

Other funds holding ALKS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Loring Wolcott & Coolidge Fiduciary Advisors's ALKS Position: Q2 2020 in Review

Loring Wolcott & Coolidge Fiduciary Advisors sold out of Alkermes (ALKS) in Q2 2020, closing a stake of 1,250 shares — an estimated $18K sold.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in ALKS in Q4 2019 and held it in 2 quarters. The position peaked at $26K in Q4 2019. 171 funds tracked by Wall St. Rank hold ALKS as of Q2 2020.

  • Loring Wolcott & Coolidge Fiduciary Advisors reported no remaining Alkermes position as of Q2 2020 after selling out during the quarter.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 1,250 Alkermes shares in Q2 2020, an estimated $18K.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Alkermes in Q4 2019 and held it in 2 quarters.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Alkermes position peaked at $26K in Q4 2019.
  • 171 funds tracked by Wall St. Rank held Alkermes as of Q2 2020.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2020, filed 30 Jul 2020.